Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
==============================================================================================================================

* Zi-Xian Wang
* Hao-Xiang Wu
* Li Xie
* Wu-Hao Lin
* Fei Liang
* Jin Li
* Zhi-Min Yang
* Rui-Hua Xu